Indefinite Delivery Contract SPE2DR25D9332

The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) valued at $4,999,999.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The contract, which runs through December 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which aims to establish multiple regional contracts to increase the Department of Defense's resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The original solicitation was open to all responsible sources and did not use any set-asides.